Viridian Therapeutics, Inc. (VRDN) Earnings
NASDAQ·Healthcare·Biotechnology
$16.35
+1.43%
Mkt Cap $1.47B
EPS — Estimate vs Actual
Mkt Cap
$1.47B
P/E
—
Fwd P/E
—
P/S
21.03
Rev TTM
—
EPS TTM
-$3.48
NASDAQ·Healthcare·Biotechnology
$16.35
+1.43%
Mkt Cap $1.47B
Mkt Cap
$1.47B
P/E
—
Fwd P/E
—
P/S
21.03
Rev TTM
—
EPS TTM
-$3.48